Загрузка...
Crizotinib-induced pancreatic pseudocyst: a novel adverse event
Crizotinib is a tyrosine kinase inhibitor that demonstrates a dramatic tumour response in patients with advanced non-small cell lung cancers harbouring anaplastic lymphoma kinase (ALK) rearrangement. The pancreatic cyst has never been reported in patients who received crizotinib, whereas crizotinib-...
Сохранить в:
| Опубликовано в: : | BMJ Case Rep |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4567757/ https://ncbi.nlm.nih.gov/pubmed/26351314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2015-211556 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|